Publication | Closed Access

Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial

Rheumatoid DisorderRheumatologySystemic TreatmentRheumatic DiseasesClinical TrialsInflammatory Rheumatic DiseaseParallel-group Swefot TrialMedicineOrthopaedic SurgeryYear Follow-upRheumatoid Arthritis